Octagos Health, a Houston, TX-based supplier of AI-driven cardiac system monitoring options, raised over $43M in Sequence B funding.
The spherical was led by Morgan Stanley Enlargement Capital, with participation from Mucker Capital and different strategic buyers.
The corporate intends to make use of the funds to speed up enhancements to its platform, along with scaling its industrial group and operations.
Led by CEO Dr. Shanti Bansal, Octagos Well being is a supplier of cardiac monitoring options, devoted to enhancing affected person outcomes via expertise and complete monitoring companies. Its AI-driven platform affords steady monitoring and information evaluation for sufferers with implantable cardiac units, enabling healthcare suppliers to make knowledgeable selections and ship well timed care. Octagos Well being’s options are designed to combine with digital well being information and supply customizable reporting options, making it an important software for contemporary healthcare establishments.
FinSMEs
10/07/2024
